Literature DB >> 11458817

Current status of ribozymes as gene therapy agents for cancer.

L Wright1, P Kearney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11458817     DOI： 10.1081/cnv-100103848

Source DB:  PubMed          Journal:  Cancer Invest        ISSN： 0735-7907            Impact factor:   2.176


× No keyword cloud information.
  3 in total

Review 1.  Therapeutic regulation of gene expression in the inner ear using RNA interference.

Authors:  Yukihide Maeda; Abraham M Sheffield; Richard J H Smith
Journal:  Adv Otorhinolaryngol       Date:  2009-06-02

2.  Ribozyme-mediated REV1 inhibition reduces the frequency of UV-induced mutations in the human HPRT gene.

Authors:  Denise R Clark; Wolfgang Zacharias; Luminita Panaitescu; W Glenn McGregor
Journal:  Nucleic Acids Res       Date:  2003-09-01       Impact factor: 16.971

3.  Catalytic nucleic acid enzymes for the study and development of therapies in the central nervous system: Review Article.

Authors:  Richard Tritz; Cellia Habita; Joan M Robbins; German G Gomez; Carol A Kruse
Journal:  Gene Ther Mol Biol       Date:  2005
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.